Literature DB >> 35361499

Insulin action in the brain: cell types, circuits, and diseases.

Wenqiang Chen1, Weikang Cai2, Benjamin Hoover3, C Ronald Kahn4.   

Abstract

Since its discovery over 100 years ago, insulin has been recognized as a key hormone in control of glucose homeostasis. Deficiencies of insulin signaling are central to diabetes and many other disorders. The brain is among the targets of insulin action, and insulin resistance is a major contributor to many diseases, including brain disorders. Here, we summarize key roles of insulin action in the brain and how this involves different brain cell types. Disordered brain insulin signaling can also contribute to neuropsychiatric diseases, affecting brain circuits involved in mood and cognition. Understanding of insulin signaling in different brain cell types/circuits and how these are altered in disease may lead to the development of new therapeutic approaches to these challenging disorders.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s diseases; astrocytes; depression; diabetes; insulin resistance; neurons

Mesh:

Substances:

Year:  2022        PMID: 35361499      PMCID: PMC9035105          DOI: 10.1016/j.tins.2022.03.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   16.978


  150 in total

1.  GABAergic Inputs to POMC Neurons Originating from the Dorsomedial Hypothalamus Are Regulated by Energy State.

Authors:  Andrew R Rau; Shane T Hentges
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

Review 2.  Inflammatory mechanisms linking obesity and metabolic disease.

Authors:  Alan R Saltiel; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

3.  Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

Authors:  Suzanne Craft; Laura D Baker; Thomas J Montine; Satoshi Minoshima; G Stennis Watson; Amy Claxton; Matthew Arbuckle; Maureen Callaghan; Elaine Tsai; Stephen R Plymate; Pattie S Green; James Leverenz; Donna Cross; Brooke Gerton
Journal:  Arch Neurol       Date:  2011-09-12

Review 4.  Insulin receptor signaling in normal and insulin-resistant states.

Authors:  Jérémie Boucher; André Kleinridders; C Ronald Kahn
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

Review 5.  Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.

Authors:  Christian Rask-Madsen; C Ronald Kahn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 6.  Intranasal insulin and orexins to treat age-related cognitive decline.

Authors:  Jennifer M Erichsen; Coleman B Calva; Lawrence P Reagan; Jim R Fadel
Journal:  Physiol Behav       Date:  2021-02-21

7.  Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury.

Authors:  Laura Genis; David Dávila; Silvia Fernandez; Andrea Pozo-Rodrigálvarez; Ricardo Martínez-Murillo; Ignacio Torres-Aleman
Journal:  F1000Res       Date:  2014-01-28

8.  Heterogeneity of hypothalamic pro-opiomelanocortin-expressing neurons revealed by single-cell RNA sequencing.

Authors:  Brian Y H Lam; Irene Cimino; Joseph Polex-Wolf; Sara Nicole Kohnke; Debra Rimmington; Valentine Iyemere; Nicholas Heeley; Chiara Cossetti; Reiner Schulte; Luis R Saraiva; Darren W Logan; Clemence Blouet; Stephen O'Rahilly; Anthony P Coll; Giles S H Yeo
Journal:  Mol Metab       Date:  2017-03-01       Impact factor: 7.422

9.  Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man.

Authors:  A Santi; M Bot; A Aleman; B W J H Penninx; I Torres Aleman
Journal:  Transl Psychiatry       Date:  2018-08-01       Impact factor: 6.222

10.  Diametric neural ensemble dynamics in parkinsonian and dyskinetic states.

Authors:  Jones G Parker; Jesse D Marshall; Biafra Ahanonu; Yu-Wei Wu; Tony Hyun Kim; Benjamin F Grewe; Yanping Zhang; Jin Zhong Li; Jun B Ding; Michael D Ehlers; Mark J Schnitzer
Journal:  Nature       Date:  2018-05-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.